Companion Diagnostics Global Market Report 2022 – By Service Type (Integration And Support, Automation And Orchestration, Billing And Provisioning, Migration And Customization, Security And Compliance), By Platform Type (Internal Brokerage Enablement, External Brokerage Enablement), By Organization Size (Small And Medium-Sized Enterprises (SMEs), Large Enterprises), By Verticals (Banking, Financial Services, And Insurance (BFSI), Telecommunications, Information Technology (IT) And Information Technology Enabled Services (ITeS), Government And Public Sector, Retail And Consumer Goods, Manufacturing, Energy And Utilities, Media And Entertainment, Healthcare And Life Sciences) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 175 | Published : September 2022 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The companion diagnostics market consists of sales of companion diagnostics solutions and services by entities (organizations, sole traders, and partnerships) that have an in vitro diagnostic medical device used to check the safety and effectivity of a corresponding drug or biological product. The test aids a medical expert in matching a patient to a specific drug or therapy.

The main products and services of Companion Diagnostics are assays, kits and reagents, and software and services. Assays, kits, and reagents are used in various life science, environmental, and research labs. An assay is a procedure for examining a substance to ascertain its composition or quality. A kit is a set or collection of equipment, materials, or instructions for a particular use. A reagent is a chemical used in laboratory testing to make, measure, or detect other compounds. Polymerase chain reaction, next-generation sequencing, in situ hybridization, and immunohistochemistry are the technologies used in companion diagnostics. The companion diagnostics are used for identifying lung, breast, colorectal, leukemia, and melanoma cancer diseases. Pharmaceutical and biopharmaceutical companies, reference laboratories, and contract research organizations use companion diagnostics.

The companion diagnostics market research report is one of a series of new reports from The Business Research Company that provides companion diagnostics market statistics, including companion diagnostics industry global market size, regional shares, competitors with a companion diagnostics market share, detailed companion diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the companion diagnostics industry. This companion diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global companion diagnostics market size is expected to grow from $4.37 billion in 2021 to $5.15 billion in 2022 at a compound annual growth rate (CAGR) of 17.86%. The global companion diagnostics market size is expected to reach $9.99 billion in 2026 at a compound annual growth rate (CAGR) of 18.01%.

The increasing number of targeted therapies is expected to propel the growth of the companion diagnostics market. Targeted therapy is a pharmacological therapy that targets particular characteristics of cancer cells to inhibit the growth and spread of the disease. The medications circulate throughout the body but have a more targeted effect than chemotherapy and frequently have fewer adverse effects. Biological marker-based companion diagnostic testing for targeted cancer therapy is becoming an essential part of personalized cancer care. According to the April 2021 article of the European Society for Medical Oncology, the genome-targeted therapy estimated eligibility was 8.82% by the end of 2018 and increased to 13.60% in 2020. Therefore, the rising number of therapies drives the companion diagnostics market.

Technological advancement is a key trend in the companion diagnostics market. Artificial intelligence is used to develop more efficient drugs for companion diagnostics. The continuously gathered massive data sets from diverse genetic profiling have enabled the widespread application of AI. For instance, Deep Genomics, a Toronto-based start-up, is utilizing artificial intelligence to uncover better medications for genetic illnesses and speed up their introduction into clinical trials. The goal is to employ deep learning to explore the human genome for knowledge about the causes of diseases and to create and test chemical compounds that can be used as remedies. In a computer model, deep learning enables scientists to test billions of chemical compounds in search of promising formulations that they can turn into medicines that save lives for people worldwide.

In April 2021, Agilent Technologies Inc., a US-based analytical laboratory company that manufactures instruments, reagents, software, services, and consumables for comprehensive laboratory workflow, acquired Resolution Bioscience for $695 million. With this acquisition, Agilent's strengths in NGS-based cancer diagnostics are complemented and expanded, and it also gives the company access to technology to meet the demands of the rapidly expanding precision medicine sector. Resolution Bioscience is a US-based healthcare research company specializing in NGS technology, molecular biology, cancer diagnostics, and more.

Major players in the companion diagnostics market are F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Qiagen NV, Thermo Fisher Scientific Inc, Abbott Laboratories Inc, Myriad Genetics Inc, Almac Group, Illumina Inc, Seimens Healthineers AG, Abnova Corporation, Guardant Health Inc, ARUP Laboratories Inc, Foundation Medicine Inc, Bayer AG, Clinical Lab Products, Leica Biosystems Nussloch GmbH, and Life Technologies Tm.

North America was the largest region in the companion diagnostics market in 2021. The regions covered in the global companion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the companion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The global companion diagnostics market is segmented -

1) By Product and Service: Assays, Kits and Reagents, Software and Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry

3) By Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma

4) By End-User: Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations

    Table Of Contents

    1. Executive Summary

    2. Companion Diagnostics Market Characteristics

    3. Companion Diagnostics Market Trends And Strategies

    4. Impact Of COVID-19 On Companion Diagnostics

    5. Companion Diagnostics Market Size And Growth

    5.1. Global Companion Diagnostics Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Companion Diagnostics Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Companion Diagnostics Market Segmentation

    6.1. Global Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Assays, Kits And Reagents

    Software And Services

    6.2. Global Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Polymerase Chain Reaction

    Next-Generation Sequencing

    In Situ Hybridization

    Immunohistochemistry

    6.3. Global Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Lung Cancer

    Breast Cancer

    Colorectal Cancer

    Leukemia

    Melanoma

    6.4. Global Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Pharmaceutical And Biopharmaceutical Companies

    Reference Laboratories

    Contract Research Organizations

    7. Companion Diagnostics Market Regional And Country Analysis

    7.1. Global Companion Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Companion Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Companion Diagnostics Market

    8.1. Asia-Pacific Companion Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Companion Diagnostics Market

    9.1. China Companion Diagnostics Market Overview

    9.2. China Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Companion Diagnostics Market

    10.1. India Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Companion Diagnostics Market

    11.1. Japan Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Companion Diagnostics Market

    12.1. Australia Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Companion Diagnostics Market

    13.1. Indonesia Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Companion Diagnostics Market

    14.1. South Korea Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Companion Diagnostics Market

    15.1. Western Europe Companion Diagnostics Market Overview

    15.2. Western Europe Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Companion Diagnostics Market

    16.1. UK Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Companion Diagnostics Market

    17.1. Germany Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Companion Diagnostics Market

    18.4. France Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.5. France Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Companion Diagnostics Market

    19.1. Eastern Europe Companion Diagnostics Market Overview

    19.2. Eastern Europe Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Companion Diagnostics Market

    20.1. Russia Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Companion Diagnostics Market

    21.1. North America Companion Diagnostics Market Overview

    21.2. North America Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Companion Diagnostics Market

    22.1. USA Companion Diagnostics Market Overview

    22.2. USA Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Companion Diagnostics Market

    23.1. South America Companion Diagnostics Market Overview

    23.2. South America Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Companion Diagnostics Market

    24.1. Brazil Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Companion Diagnostics Market

    25.1. Middle East Companion Diagnostics Market Overview

    25.2. Middle East Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Companion Diagnostics Market

    26.1. Africa Companion Diagnostics Market Overview

    26.2. Africa Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Companion Diagnostics Market Competitive Landscape And Company Profiles

    27.1. Companion Diagnostics Market Competitive Landscape

    27.2. Companion Diagnostics Market Company Profiles

    27.2.1. F Hoffmann-La Roche Ltd

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Agilent Technologies Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Qiagen NV

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Thermo Fisher Scientific Inc

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Abbott Laboratories Inc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Companion Diagnostics Market

    29. Companion Diagnostics Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1, Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2, Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3, Global Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4, Global Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5, Global Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6, Global Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7, Global Companion Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8, Global Companion Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9, Asia-Pacific, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10, Asia-Pacific, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11, China, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12, China, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13, India, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14, India, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15, Japan, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16, Japan, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17, Australia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18, Australia, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19, Indonesia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20, Indonesia, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21, South Korea, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22, South Korea, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23, Western Europe, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24, Western Europe, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25, UK, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26, UK, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27, Germany, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28, Germany, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29, France, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30, France, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31, Eastern Europe, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32, Eastern Europe, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33, Russia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34, Russia, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35, North America, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36, North America, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37, USA, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38, USA, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39, South America, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40, South America, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41, Brazil, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42, Brazil, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43, Middle East, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44, Middle East, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45, Africa, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46, Africa, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 47, F Hoffmann-La Roche Ltd Financial Performance
  • Table 48, Agilent Technologies Inc Financial Performance
  • Table 49, Qiagen NV Financial Performance
  • Table 50, Thermo Fisher Scientific Inc Financial Performance
  • Table 51, Abbott Laboratories Inc Financial Performance

List Of Figures

    Figure 1, Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2, Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3, Global Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4, Global Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5, Global Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6, Global Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7, Global Companion Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8, Global Companion Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9, Asia-Pacific, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10, Asia-Pacific, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11, China, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12, China, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13, India, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14, India, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15, Japan, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16, Japan, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17, Australia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18, Australia, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19, Indonesia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20, Indonesia, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21, South Korea, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22, South Korea, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23, Western Europe, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24, Western Europe, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25, UK, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26, UK, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27, Germany, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28, Germany, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29, France, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30, France, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31, Eastern Europe, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32, Eastern Europe, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33, Russia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34, Russia, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35, North America, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36, North America, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37, USA, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38, USA, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39, South America, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40, South America, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41, Brazil, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42, Brazil, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43, Middle East, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44, Middle East, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45, Africa, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46, Africa, Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 47, F Hoffmann-La Roche Ltd Financial Performance
  • Figure 48, Agilent Technologies Inc Financial Performance
  • Figure 49, Qiagen NV Financial Performance
  • Figure 50, Thermo Fisher Scientific Inc Financial Performance
  • Figure 51, Abbott Laboratories Inc Financial Performance
Global Diabetic Footwear Market Overview And Prospects – Includes Diabetic Footwear Market Size
Global Electric Toothbrush Market Outlook, Opportunities And Strategies – Includes Electric Toothbrush Market Analysis
Global Medical Tubing Market Outlook, Opportunities And Strategies – Includes Medical Tubing Market Trends
Global Injectable Drug Delivery Devices Market Overview And Prospects – Includes Injectable Drug Delivery Devices Market Growth
Global Interventional Oncology Devices Market Outlook, Opportunities And Strategies – Includes Interventional Oncology Devices Market Analysis
Global Voice Prosthesis Devices And Equipment Market Outlook, Opportunities And Strategies – Includes Voice Prosthesis Devices And Equipment Market Size
Global Dental Implants Market Overview And Prospects – Includes Dental Implants Market Share
Global Masks (N95 Respirators And Other Surgical Masks) Market Size, Forecasts, And Opportunities – Includes Masks (N95 Respirators And Other Surgical Masks) Market Growth
Enteric Disease Testing Global Market Report 2022 – By Disease Type (Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types), By Technology (Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography And Spectrometry, Other Technologies), By Application (Hospitals, Research Centers, Clinics, Other Applications) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Cancer Tumor Profiling Global Market Report 2022 – By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray), By Process Type (Genomics, Proteomics, Epigenetics, Metabolomics), By Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Next Generation Sequencing Global Market Report 2022 – By Product (NextSeq Systems, MiniSeq Systems, NovaSeq Systems, iSeq 100 Systems, Ion PGM Systems, Ion Proton Systems, Ion GeneStudio S5 Systems, PacBio RS II Systems, Sequel Systems, Other Products), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies), By Application (Diagnostics, Drug Discovery, Other Applications) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Clinical Oncology Next Generation Sequencing Global Market Report 2022 – By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing), By Application (Screening, Companion Diagnostics, Other Diagnostics), By End-User (Hospital Laboratories, Clinical Research Organizations, Diagnostic laboratories) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2022 – By Product (Instruments, Reagents, Consumables), By End User (Pharmaceutical and Biotechnoly Industries, Clinical Diagnostics Labs and Hospitals, Academics and Research Organization), By Instruments (Standars PCR, RT-PCR, Digital PCR) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Single-Cell Analysis Global Market Report 2022 – By Product (Consumables, Instruments), By Workflow (Single-cell Isolation And Library Preparation, Downstream Analysis, Data Analysis), By Technique (Flow Cytometry, Next Generation Sequencing, Polymerase Chain Reaction (PCR), Microscopy, Mass Spectrometry, Other Techniques) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Influenza Diagnostics Market 2022 – By Traditional Diagnostic Tests (Rapid Influenza Diagnostics Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests), By Molecular Diagnostic Tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By End-User (Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users), And By Region, Opportunities And Strategies – Global Forecast To 2031 
View Report
Molecular Diagnostics Global Market Report 2022 – By Technology (Polymerase Chain Reaction (PCR), DNA Sequencing, and Next-Generation Sequencing), By Product (Instruments, Reagents and Consumables, Software and Services), By Application (Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, and Other Applications), By End-User (Hospitals, Laboratories, and Other End-Users (Blood Banks, Home Health Agencies, and Nursing Homes) – Market Size, Trends, And Global Forecast 2022-2026
View Report